Michael C. Donegan, CAO and VP Finance at TherapeuticsMD, Inc. (TXMD), sold 4,842 shares at $1.04 ($5K) on 2021-05-11, disclosed to the SEC on 2021-05-12.
Open-market sale of $5k TXMD by CAO and VP Finance. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TXMD | SELL | 2022-12-09 | $4K | — | Filing → |
| TXMD | SELL | 2021-12-02 | $16K | — | Filing → |